RNAi Reveals Phase-Specific Global Regulators of Human Somatic Cell Reprogramming
Cheng-Xu Delon Toh,
Jun-Wei Chan,
Zheng-Shan Chong,
Hao Fei Wang,
Hong Chao Guo,
Sandeep Satapathy,
Dongrui Ma,
Germaine Yen Lin Goh,
Ekta Khattar,
Lin Yang,
Vinay Tergaonkar,
Young-Tae Chang,
James J. Collins,
George Q. Daley,
Keng Boon Wee,
Chadi A. EL Farran,
Hu Li,
Yoon-Pin Lim,
Frederic A. Bard,
Yuin-Han Loh
Affiliations
Cheng-Xu Delon Toh
Epigenetics and Cell Fates Laboratory, A∗STAR Institute of Molecular and Cell Biology, 61 Biopolis Drive Proteos, Singapore 138673, Singapore
Jun-Wei Chan
Epigenetics and Cell Fates Laboratory, A∗STAR Institute of Molecular and Cell Biology, 61 Biopolis Drive Proteos, Singapore 138673, Singapore
Zheng-Shan Chong
Epigenetics and Cell Fates Laboratory, A∗STAR Institute of Molecular and Cell Biology, 61 Biopolis Drive Proteos, Singapore 138673, Singapore
Hao Fei Wang
Epigenetics and Cell Fates Laboratory, A∗STAR Institute of Molecular and Cell Biology, 61 Biopolis Drive Proteos, Singapore 138673, Singapore
Hong Chao Guo
Epigenetics and Cell Fates Laboratory, A∗STAR Institute of Molecular and Cell Biology, 61 Biopolis Drive Proteos, Singapore 138673, Singapore
Sandeep Satapathy
Epigenetics and Cell Fates Laboratory, A∗STAR Institute of Molecular and Cell Biology, 61 Biopolis Drive Proteos, Singapore 138673, Singapore
Dongrui Ma
Research and Development Unit (RDU), National Heart Centre Singapore, 5th Hospital Drive, Singapore 169609, Singapore
Germaine Yen Lin Goh
Membrane Traffic Laboratory, A∗STAR Institute of Molecular and Cell Biology, 61 Biopolis Drive Proteos, Singapore 138673, Singapore
Ekta Khattar
Division of Cancer Genetics and Therapeutics, Laboratory of NF-κB Signaling, A∗STAR Institute of Molecular and Cell Biology, 61 Biopolis Drive Proteos, Singapore 138673, Singapore
Lin Yang
Department of Molecular Biology, Massachusetts General Hospital, Boston, MA 02114, USA
Vinay Tergaonkar
Division of Cancer Genetics and Therapeutics, Laboratory of NF-κB Signaling, A∗STAR Institute of Molecular and Cell Biology, 61 Biopolis Drive Proteos, Singapore 138673, Singapore
Young-Tae Chang
Lab of Bioimaging Probe Development, A∗STAR Singapore Bioimaging Consortium (SBIC), 11 Biopolis Way Helios, Singapore 138673, Singapore
James J. Collins
Howard Hughes Medical Institute, Boston, MA 02114, USA
George Q. Daley
Howard Hughes Medical Institute, Boston, MA 02114, USA
Keng Boon Wee
A∗STAR Institute of High Performance Computing (IHPC), Connexis, Singapore 138632, Singapore
Chadi A. EL Farran
Epigenetics and Cell Fates Laboratory, A∗STAR Institute of Molecular and Cell Biology, 61 Biopolis Drive Proteos, Singapore 138673, Singapore
Hu Li
Center for Individualized Medicine, Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN 55905, USA
Yoon-Pin Lim
NUS Graduate School for Integrative Sciences and Engineering, National University of Singapore, 28 Medical Drive, Singapore 117456, Singapore
Frederic A. Bard
Membrane Traffic Laboratory, A∗STAR Institute of Molecular and Cell Biology, 61 Biopolis Drive Proteos, Singapore 138673, Singapore
Yuin-Han Loh
Epigenetics and Cell Fates Laboratory, A∗STAR Institute of Molecular and Cell Biology, 61 Biopolis Drive Proteos, Singapore 138673, Singapore
Incomplete knowledge of the mechanisms at work continues to hamper efforts to maximize reprogramming efficiency. Here, we present a systematic genome-wide RNAi screen to determine the global regulators during the early stages of human reprogramming. Our screen identifies functional repressors and effectors that act to impede or promote the reprogramming process. Repressors and effectors form close interacting networks in pathways, including RNA processing, G protein signaling, protein ubiquitination, and chromatin modification. Combinatorial knockdown of five repressors (SMAD3, ZMYM2, SFRS11, SAE1, and ESET) synergistically resulted in ∼85% TRA-1-60-positive cells. Removal of the novel splicing factor SFRS11 during reprogramming is accompanied by rapid acquisition of pluripotency-specific spliced forms. Mechanistically, SFRS11 regulates exon skipping and mutually exclusive splicing of transcripts in genes involved in cell differentiation, mRNA splicing, and chromatin modification. Our study provides insights into the reprogramming process, which comprises comprehensive and multi-layered transcriptional, splicing, and epigenetic machineries.